
Viraferonpeg 120mcg Injection
Marketer
MSD Pharmaceuticals Pvt Ltd
Salt Composition
Pegylated Interferon Alpha 2B (120mcg)
Overview Viraferonpeg 120mcg Injection
Peg-interferon alfa-2b 120 mcg injection treats chronic hepatitis C (HCV). Administration is by a healthcare professional via injection, continuing as directed by your physician. Treatment length depends on individual response. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Benefits may not be apparent for weeks or months; discontinue only with your doctor's guidance. Common side effects include headache, dizziness, sleeplessness, nausea, and vomiting. This medication can decrease blood cell counts, raising infection risk. Report fever, chills, rash, breathing difficulties, unusual bleeding/bruising, or dark urine immediately. Regular blood tests monitor blood cell levels, thyroid, liver, kidney function, and electrolytes. Prior to starting treatment, disclose any liver, kidney disease, or mental health conditions. Report mood changes, depression, vision problems, or suicidal thoughts. Inform your doctor of all other medications, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.
Primary Ingredients of Viraferonpeg 120mcg Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Viraferonpeg 120mcg Injection
Persistent infection with the hepatitis C virus (HCV)
Major Benefits of Viraferonpeg 120mcg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Viraferonpeg 120mcg Injection:
- Abdominal pain
- Agitation
- Anxiety
- Blurred vision
- Cough
- Decreased appetite
- Decreased white blood cell count
- Depression
- Dizziness
- Dryness in mouth
- Fatigue
- Headache
- Impaired concentration
- Indigestion
- Insomnia (difficulty in sleeping)
- Nausea
- Nervousness
- Sore throat
- Stomatitis (Inflammation of the mouth)
- Viral infection
- Vomiting
How to use Viraferonpeg 120mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Viraferonpeg 120mcg Injection works:
Peginterferon alfa-2a 120mcg injection influences the body's immune response.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Viraferonpeg 120mcg Injection alongside alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of the injectable medication Viraferonpeg 120mcg during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is recommended.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Viraferonpeg 120mcg Injection safely. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Administration of Viraferonpeg 120mcg Injection may induce adverse reactions impacting driving aptitude. Dizziness, cognitive impairment, drowsiness, and tiredness are potential effects; therefore, patients should refrain from operating vehicles.
KidneyUNSAFE
Individuals with kidney disease should likely avoid Viraferonpeg 120mcg Injection due to potential safety concerns. Medical advice is recommended. Exercise caution when administering this injection to patients with reduced kidney function.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Viraferonpeg 120mcg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Viraferonpeg 120mcg Injection :
Should you forget a Viraferonpeg 120mcg Injection dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Viraferonpeg 120mcg Injection
| Label | Value |
|---|---|
| Chemical Category | Interferon proteins |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Interferon proteins |
